1,3-Butanediol

From Wikipedia, the free encyclopedia
(Redirected from E1502)

Template:Cs1 config Page Template:Chembox/styles.css has no content.

Template:Chembox IndexlistTemplate:Chembox CompToxTemplate:Chembox GHS (set)Template:Chembox Datapage check
1,3-Butanediol
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Names
Preferred IUPAC name
Butane-1,3-diol
Other names
1,3-butylene glycol, butane-1,3-diol, or 1,3-dihydroxybutane
Identifiers
Page Template:Plainlist/styles.css has no content.
3D model (JSmol)
Page Template:Plainlist/styles.css has no content.
1731276

1718944 (R)
1718943 (S)

ChEBI Page Template:Plainlist/styles.css has no content.
ChEMBL Page Template:Plainlist/styles.css has no content.
ChemSpider Page Template:Plainlist/styles.css has no content.
DrugBank Page Template:Plainlist/styles.css has no content.
EC Number Page Template:Plainlist/styles.css has no content.
2409

2493173 (R)
1994384 (S)

KEGG Page Template:Plainlist/styles.css has no content.
MeSH 1,3-Butylene+glycol
Page Template:Plainlist/styles.css has no content.
RTECS number Page Template:Plainlist/styles.css has no content.
UNII Page Template:Plainlist/styles.css has no content.
  • InChI=1S/C4H10O2/c1-4(6)2-3-5/h4-6H,2-3H2,1H3 N
    Key: PUPZLCDOIYMWBV-UHFFFAOYSA-N N
  • CC(O)CCO
Properties
C4H10O2
Molar mass 90.122 g·mol−1
Appearance Colourless liquid
Density 1.0053 g cm−3
Melting point −50 °C (−58 °F; 223 K)
Boiling point 204 to 210 °C; 399 to 410 °F; 477 to 483 K
1 kg dm−3
log P −0.74
Vapor pressure 8 Pa (at 20 °C)
1.44
Thermochemistry
227.2 J K−1 mol−1
−501 kJ mol−1
−2.5022 MJ mol−1
Hazards
NFPA 704 (fire diamond) Page Template:NFPA 704 diamond/styles.css has no content.

Error: Image is invalid or non-existent.

1
1
0
Flash point 108 °C (226 °F; 381 K)
394 °C (741 °F; 667 K)
Related compounds
Related butanediol
1,2-Butanediol

1,4-Butanediol
2,3-Butanediol

Related compounds
2-Methylpentane
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is checkYN ?)

Template:Chembox Footer/trackingTemplate:Short description

1,3-Butanediol is an organic compound with the formula CH3CH(OH)CH2CH2OH, not to be confused with 1,4 Butanediol. With two alcohol functional groups, the molecule is classified as a diol. The compound without the R (or D) designation is racemic, which is what has been used in most studies before 2023. The compound is a colorless, bittersweet, water-soluble liquid. It is one of four common structural isomers of butanediol.[1][2][3] It is used in grape flavoring,[4] and as a precursor to some antibiotics.[5]

Production and uses

Hydrogenation of 3-hydroxybutanal gives 1,3-butanediol:[6]

CH3CH(OH)CH2CHO + H2 → CH3CH(OH)CH2CH2OH

Dehydration of 1,3-butanediol gives 1,3-butadiene:

CH3CH(OH)CH2CH2OH → CH2=CH-CH=CH2 + 2 H2O

Pharmacology

1,3-Butanediol has sedative, hypotensive and hypoglycaemic action comparable to ethanol, with the (R), also known as (D), enantiomer being more active.[7][8] Fatty acid esters of 1,3-butanediol such as the acetoacetate, lactate or hexanoate have been studied for inducing ketogenesis.[9][10][11][12][13][14][15]

Occurrence

1,3-Butanediol has been detected in bell peppers (Capsicum annuum).[16] 1,3 Butanediol maintains FDA GRAS status as a flavor molecule.[17]

References

Page Template:Reflist/styles.css has no content.

  1. ^ Script error: No such module "Template wrapper".
  2. ^ Page Module:Citation/CS1/styles.css has no content."1,3 Butylene Glycol". Parchem Fine & Specialty Chemicals.
  3. ^ Page Module:Citation/CS1/styles.css has no content.Dymsza HA (November 1975). "Nutritional application and implication of 1,3-butanediol". Federation Proceedings. 34 (12): 2167–2170. PMID 1102338.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Dymsza HA (Nov 1975). "Nutritional application and implication of 1,3-butanediol". Fed Proc. 34 (12): 2167–70. PMID 1102338.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Guo X, Gao Y, Liu F, Tao Y, Jin H, Wang J, et al. (June 2023). "A short-chain carbonyl reductase mutant is an efficient catalyst in the production of (R)-1,3-butanediol". Microbial Biotechnology. 16 (6): 1333–1343. doi:10.1111/1751-7915.14249. PMC 10221522. PMID 36946330.
  6. ^ Script error: No such module "Template wrapper".
  7. ^ Page Module:Citation/CS1/styles.css has no content.Frye GD, Chapin RE, Vogel RA, Mailman RB, Kilts CD, Mueller RA, et al. (February 1981). "Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol". The Journal of Pharmacology and Experimental Therapeutics. 216 (2): 306–314. doi:10.1016/S0022-3565(25)32419-5. PMID 7193248.
  8. ^ Page Module:Citation/CS1/styles.css has no content.Lowder J, Fallah S, Venditti C, Musa-Veloso K, Kotlov V (2023). "An open-label, acute clinical trial in adults to assess ketone levels, gastrointestinal tolerability, and sleepiness following consumption of (R)-1,3-butanediol (Avela™)". Frontiers in Physiology. 14 1195702. doi:10.3389/fphys.2023.1195702. PMC 10338333. PMID 37457035.
  9. ^ Page Module:Citation/CS1/styles.css has no content.Hashim SA, VanItallie TB (September 2014). "Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester". Journal of Lipid Research. 55 (9): 1818–1826. doi:10.1194/jlr.R046599. PMC 4617348. PMID 24598140.
  10. ^ Page Module:Citation/CS1/styles.css has no content.Place DE, Kanneganti TD (March 2019). "Fueling Ketone Metabolism Quenches Salt-Induced Hypertension". Trends in Endocrinology and Metabolism. 30 (3): 145–147. doi:10.1016/j.tem.2019.01.004. PMID 30670332.
  11. ^ Page Module:Citation/CS1/styles.css has no content.Evans M, McClure TS, Koutnik AP, Egan B (December 2022). "Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future". Sports Medicine. 52 (Suppl 1): 25–67. doi:10.1007/s40279-022-01756-2. PMC 9734240. PMID 36214993.
  12. ^ Page Module:Citation/CS1/styles.css has no content.Mah E, Blonquist TM, Kaden VN, Beckman D, Boileau AC, Anthony JC, et al. (2023). "A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestion in healthy adults". Frontiers in Physiology. 14 1196535. doi:10.3389/fphys.2023.1196535. PMC 10324611. PMID 37427402.
  13. ^ Page Module:Citation/CS1/styles.css has no content.Stubbs BJ, et al. (2023). "A randomized, open-label, cross-over pilot study investigating metabolic product kinetics of the palatable novel ketone ester, bis-octanoyl (R)-1,3-butanediol, and bis-hexanoyl (R)-1,3-butanediol ingestion in healthy adults". Toxicology Research and Application. doi:10.1177/23978473231197835.
  14. ^ Page Module:Citation/CS1/styles.css has no content.Deemer SE, Roberts BM, Smith DL, Plaisance EP, Philp A (July 2024). "Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity". American Journal of Physiology. Cell Physiology. 327 (1): C140–C150. doi:10.1152/ajpcell.00471.2023. PMID 38766768.
  15. ^ Page Module:Citation/CS1/styles.css has no content.Ottosen RN, et al. (2024). "Preparation and Preclinical Characterization of a Simple Ester for Dual Exogenous Supply of Lactate and Beta-hydroxybutyrate". Journal of Agricultural and Food Chemistry. 72 (36): 19883–19890. doi:10.1021/acs.jafc.4c04849. PMC 11403612.
  16. ^ Page Module:Citation/CS1/styles.css has no content."Metabocard for 1,3-Butanediol". Human Metabolome Database. HMDB0031320. Retrieved 2022-05-12.
  17. ^ Page Module:Citation/CS1/styles.css has no content."FDA GRAS for 1,3 Butanediol for flavoring CFR - Code of Federal Regulations Title 21". www.accessdata.fda.gov. Archived from the original on September 15, 2003. Retrieved 2022-05-12.